載入...
From promising molecules to orphan drugs: Early clinical drug development
Phase-1 (also known as “First-in-Man”) clinical trials initiate the early clinical development of possible new medicines. Patient participation in this early phase of clinical trials is rather limited. After successful phase 1 trials, further phase 2 and phase 3 clinical trials in patients may lead...
Na minha lista:
| 發表在: | Intractable Rare Dis Res |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5359349/ https://ncbi.nlm.nih.gov/pubmed/28357178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2016.01094 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|